Last reviewed 2026-05-30 · How we verify

PHTHALYLSULFATHIAZOLE

FDA-approved withdrawn Small molecule ✓ Verified May 2026 Quality 2/100

PHTHALYLSULFATHIAZOLE is a drug. It is currently FDA-approved.

Phthalylsulfathiazole is a small molecule. It has multiple synonyms, including FTALILSULFATIAZOL, NSC-66454, NSC-683525, PHTALYLSULFATHIAZOL, PHTHALYLSULFATHIAZOLE, and PHTHALYLSULFATHIAZOLE.

At a glance

Generic name	PHTHALYLSULFATHIAZOLE
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PHTHALYLSULFATHIAZOLE CI brief — competitive landscape report
PHTHALYLSULFATHIAZOLE updates RSS · CI watch RSS

Frequently asked questions about PHTHALYLSULFATHIAZOLE

What is PHTHALYLSULFATHIAZOLE?

PHTHALYLSULFATHIAZOLE is a Small molecule drug.

What development phase is PHTHALYLSULFATHIAZOLE in?

PHTHALYLSULFATHIAZOLE is FDA-approved (marketed).

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing